Truist Financial’s Cytosorbents Corp CTSO Stock Holding History

Truist Financial’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-45,000	Closed	-$162K	–	2603
2023 Q2	$162K	Hold	45,000	–	–	﹤0.01%	2468
2023 Q1	$152K	Hold	45,000	–	–	﹤0.01%	2469
2022 Q4	$69.8K	Hold	45,000	–	–	﹤0.01%	2503
2022 Q3	$61K	Hold	45,000	–	–	﹤0.01%	2457
2022 Q2	$95K	Hold	45,000	–	–	﹤0.01%	2550
2022 Q1	$144K	Hold	45,000	–	–	﹤0.01%	2582
2021 Q4	$189K	Hold	45,000	–	–	﹤0.01%	2605
2021 Q3	$365K	Hold	45,000	–	–	﹤0.01%	2210
2021 Q2	$340K	Hold	45,000	–	–	﹤0.01%	2295
2021 Q1	$391K	Hold	45,000	–	–	﹤0.01%	2126
2020 Q4	$359K	Buy	+45,000	New	+$377K	﹤0.01%	2040

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Truist Financial's CTSO Position: Q3 2023 in Review

Truist Financial sold out of Cytosorbents Corp (CTSO) in Q3 2023, closing a stake of 45,000 shares — an estimated $162K sold.

Truist Financial first reported a position in CTSO in Q4 2020 and held it in 11 quarters. The position peaked at $391K in Q1 2021. 53 funds tracked by Wall St. Rank hold CTSO as of Q3 2023.

Truist Financial reported no remaining Cytosorbents Corp position as of Q3 2023 after selling out during the quarter.
Truist Financial sold 45,000 Cytosorbents Corp shares in Q3 2023, an estimated $162K.
Truist Financial first reported a position in Cytosorbents Corp in Q4 2020 and held it in 11 quarters.
Truist Financial's Cytosorbents Corp position peaked at $391K in Q1 2021.
53 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2023.

Based on Truist Financial's 13F filing for Q3 2023, filed 14 Nov 2023.